Kvantify Secures €10M to Quantum Leap Drug Discovery

Kvantify, the Danish quantum software startup, has raised €10 million in seed funding to accelerate their mission of transforming drug discovery through quantum computing.

• Funding Details: Led by Dreamcraft Ventures, Lundbeckfonden BioCapital, and 2degrees, with additional support from Redstone VC, 2xN, and EIFO.

• Core Mission: Kvantify leverages quantum and high-performance computing to solve complex scientific and industrial challenges.

• Strategic Impact: The investment will expedite Kvantify’s development of quantum algorithms for chemical simulations, enhancing the drug discovery process.

• Investor Buzz: Hans Henrik Knudsen, Kvantify’s CEO, views this funding as a major milestone, affirming the company’s vision to revolutionize the life sciences industry.

Kvantify is poised to lead a quantum leap in drug discovery and industrial problem-solving, backed by significant investor confidence and strategic support.